Governance Incyte Corporation

INCY

US45337C1027

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 21:00:00 12/06/2026 BST			5-day change	1st Jan Change
108.53 ^USD	+0.65%		+6.01%	+9.88%

09:01am	Mirum Pharmaceuticals, Incyte Say Zilurgisertib Showed Meaningful Reductions in Heterotopic Ossification Lesion Volume During Clinical Trial	MT
06-14	Mirum Pharmaceuticals, Inc. and Incyte Report Positive Pivotal Phase 2 Results from PROGRESS Study of Zilurgisertib in Fibrodysplasia Ossificans Progressiva	CI

Executive Committee: Incyte Corporation

Manager

Positions heldSince

William Meury

58 year

Chief Executive Officer

25/06/2025

Richard Hoffman

64 year

General Counsel

30/11/2025

Soni Basi

51 year

Human Resources Officer

24/08/2025

Pablo Cagnoni

62 year

Chief Tech/Sci/R&D Officer	04/06/2023
President	04/06/2023

Michael Morrissey

62 year

Chief Tech/Sci/R&D Officer

31/12/2015

Steven Stein

59 year

Chief Tech/Sci/R&D Officer

01/03/2015

Suketu Upadhyay

57 year

Director of Finance/CFO

03/05/2026

Composition of the Board of Directors: Incyte Corporation

Director

CommitteesSince

Julian Baker

59 year

Compensation Committee	25/06/2025
Governance Committee Chair	14/06/2023
Nominating Committee Chair	14/06/2023
Governance Committee	02/06/2025
Nominating Committee	02/06/2025

Jean-Jacques Bienaimé

72 year

Governance Committee	19/01/2015
Nominating Committee	12/05/2020
Compensation Committee Chair
Audit Committee	06/11/2023
Compensation Committee
Governance Committee Chair	14/10/2025
Nominating Committee Chair	14/10/2025

Paul Clancy

64 year

Compensation Committee
Audit Committee Chair	19/01/2015
Finance Committee Chair	19/01/2015
Audit Committee
Governance Committee Chair
Nominating Committee Chair

Jacqualyn Fouse

64 year

Audit Committee	30/06/2025
Finance Committee
Governance Committee	30/06/2025
Nominating Committee	30/06/2025
Compensation Committee

Otis Brawley

66 year

Governance Committee Chair	31/03/2021
Nominating Committee Chair	31/03/2021
Compensation Committee	16/11/2021

Edmund Harrigan

73 year

Audit Committee
Finance Committee

Katherine High

74 year

Governance Committee	10/06/2019
Nominating Committee	10/06/2019

William Meury

58 year

Director/Board Member

25/06/2025

Latest Appointments: Incyte Corporation

04-28	Incyte Appoints Suketu Upadhyay as Executive Vice President, Effective May 4, 2026	CI
04-07	Palvella Therapeutics, Inc. Appoints Kent Taylor as Senior Vice President of Sales	CI
03-30	Incyte Corporation Announces Resignation of Susanne Schaffert from the Board of Directors, Effective April 15, 2026	CI
03-26	Geron Corporation Announces the Appointment of Patricia S. Andrews and Constantine Chinoporos to Board of Directors	CI
03-25	Incyte Corporation Announces Executive Changes	CI
01-07	Palvella Therapeutics, Inc. Appoints Vimal Patel as Senior Vice President of Medical Affairs	CI
12-12	Incyte Corporation Announces Resignation of Hervé Hoppenot from Board of Directors, Effective December 12, 2025	CI

More news

Former Officers and Directors: Incyte Corporation

Insider

Positions held

SinceUntil

Paula Swain

Human Resources Officer

31/12/2001

24/08/2025

Wendy Dixon

Director/Board Member	25/05/2010	13/06/2022
Independent Dir/Board Member	26/10/2011	13/06/2022

Paul Friedman

Director/Board Member	31/10/2001	25/05/2021
Chief Executive Officer	31/10/2001	12/11/2014
Independent Dir/Board Member	12/11/2014	25/05/2021
President	30/04/2004	12/11/2014

Paul Brooke

Director/Board Member	31/12/2000	25/05/2020
Independent Dir/Board Member	26/10/2011	25/05/2020

Victor Sandor

Chief Tech/Sci/R&D Officer

31/12/2009

31/08/2019

Robert Newton

Corporate Officer/Principal

31/12/2013

31/12/2018

Reid Huber

Chief Tech/Sci/R&D Officer	31/03/2014	30/11/2018
Corporate Officer/Principal	31/12/2001	31/03/2014

Richard Levy

Chief Tech/Sci/R&D Officer	31/12/2008	29/04/2016
Corporate Officer/Principal	31/07/2003	31/12/2008

James Daly

Corporate Officer/Principal

21/10/2012

25/06/2015

Richard de Schutter

Chairman	31/12/2002	21/05/2015
Independent Dir/Board Member	31/12/2002	21/05/2015

Barry Michael Ariko

Director/Board Member	31/12/2000	-
Independent Dir/Board Member	26/10/2011	-

David Hastings

Director/Board Member	30/09/2003	28/06/2012
Director of Finance/CFO	30/09/2003	30/10/2014

Roy Whitfield

Director/Board Member	31/05/1991	31/10/2001
Chief Executive Officer	31/05/1993	31/10/2001
Chairman	25/11/2001	31/05/2003
Founder	31/03/1991	27/05/2014
Treasurer	31/03/1991	31/05/1991

Patricia Andrews

Corporate Officer/Principal

19/10/2008

28/08/2012

Brian W. Metcalf

Corporate Officer/Principal

30/04/2011

Patricia A. Schreck

General Counsel	30/11/2003	31/12/2010
Corporate Secretary	30/11/2003	31/12/2010

Kim Solomon

Corporate Officer/Principal

31/12/2001

31/12/2010

Eric Siegel

General Counsel	30/09/2010	-
Corporate Secretary	31/07/2011	-

Matthew Emmens

Director/Board Member

31/12/2005

03/02/2009

John Apeler Keller

Corporate Officer/Principal

31/08/2003

11/09/2008

John F. Niblack

Director/Board Member	31/12/2005	-
Independent Dir/Board Member	26/10/2011	-

Scott W. Hurley

Comptroller/Controller/Auditor	-	14/04/2005
Treasurer	-	14/04/2005

Thomas Theriault

Chief Tech/Sci/R&D Officer

31/07/1996

31/03/2004

Richard D. Goold

Corporate Officer/Principal

31/10/2002

31/03/2004

Laurent Chardonnet

Chief Administrative Officer	-	-
Comptroller/Controller/Auditor	31/01/2004	31/05/2015
Treasurer	31/01/2004	31/05/2015

Elias Bendekgey

Director of Finance/CFO	31/12/1997	31/12/2003
General Counsel	31/12/1997	31/12/2003

James P. Merryweather

Corporate Officer/Principal

28/02/1999

31/12/2003

John M. Vuko

Director of Finance/CFO

30/11/1999

30/09/2003

Robert Stein

Chief Tech/Sci/R&D Officer	31/12/2000	31/12/2002
President	31/12/2000	31/12/2002

Wenqing Yao

Corporate Officer/Principal

27/10/2011

Steve Friedman

Chief Tech/Sci/R&D Officer	31/12/2001	01/06/2010
Corporate Officer/Principal	01/06/2010	-

Samuel T. LaBrie

Corporate Officer/Principal

31/12/2000

Tod M. Klingler

Corporate Officer/Principal

Jeffrey C. Collison

Founder

04/07/2011

Arthur Donny Strosberg

Founder

10/10/2010

Changsheng Zheng

Corporate Officer/Principal

Michelle D. Nowicki

Corporate Officer/Principal

Bhavnish Parikh

Corporate Officer/Principal

27/10/2011

Howard Goldstein

Corporate Officer/Principal

Michael Margolis

Corporate Officer/Principal

Victor Tong

Corporate Officer/Principal

Joe Don Heath

Corporate Officer/Principal

David J. Hodgson

Corporate Officer/Principal

Kenny Pollock

Corporate Officer/Principal

Steve Lincoln

Corporate Officer/Principal

15/11/2010

Daniel Maravei

Corporate Officer/Principal

27/10/2011

Sameer Harish

Corporate Officer/Principal

Thomas Tisch

Director/Board Member

Paul Chirico

Public Communications Contact

Eric Lachenmeier

Corporate Officer/Principal

Jon Saxe

Director/Board Member

Pamela M. Murphy

Investor Relations Contact	26/10/2011	-
Public Communications Contact	-	-

Stan N. Stukov

Corporate Officer/Principal

Gregory Fusco

Corporate Officer/Principal

Robert Nail

Corporate Officer/Principal

JoeBen Bevirt

Chief Tech/Sci/R&D Officer

Timothy G. Henn

Comptroller/Controller/Auditor	-	-
Director of Finance/CFO	-	-

C. James Dobbins

Corporate Officer/Principal

David Stanley Bailey

Corporate Officer/Principal

Thiru P. Reddy

Corporate Officer/Principal

Mike Hoerres

Corporate Officer/Principal

Luke I. Chen

Corporate Officer/Principal	16/02/2010	-
President	-	16/02/2010

Angeline K. Shashlo

General Counsel

Laurie King

Human Resources Officer

Sameer Rohatgi

Corporate Officer/Principal

Cate Sabatini

Corporate Officer/Principal

Dewayne McNair

Corporate Officer/Principal

Tim Germann

Corporate Officer/Principal

Aaron D. Solomon

Corporate Officer/Principal

Susan E. Daniels

Corporate Officer/Principal

Ward Davidson

Corporate Officer/Principal

Fiona Ford

Corporate Officer/Principal

17/10/2009

Michael Donovan

Corporate Officer/Principal

Debora W. Tingley

Corporate Officer/Principal

Age distribution of managers

Parity Men Women

Male	17
Female	2

Of which Executive Committee

Male	7
Female	0

Of which Directors

Male	8
Female	0

Revisions

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows: - product sales (84.7%); - royalties (12.4%); - income from research and cooperation agreements (2.9%).

Employees

2,844

Sector

Pharmaceuticals

More about the company